New Biopsy Test Predicts Early Disease Progression and Potential Survival in Patients with Advanced Breast Cancer

New Biopsy Test Predicts Early Disease Progression and Potential Survival in Patients with Advanced Breast Cancer

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a new liquid biopsy test that can be used to predict risk of early disease progression in women with metastatic breast cancer. This could help oncologists by optimizing the use of available and effective therapies with the goal of achieving better clinical outcomes and prolonging survival. Read more about the study here.

SEE ALL NEWS
Recent Posts
Podcast: Colorectal Cancer Why age matters when it comes to cancer Liquid Biopsy Predicts Response in Patients with Advanced Lung Cancer Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors What are the risk factors for Pancreatic Cancer? New Lung Tumor Scoring System Prostate Cancer: Advancements in Screenings 5 Healthy Habits That Help You During Lung Cancer Treatment Six Mammogram Myths